Health Care & Life Sciences » Pharmaceuticals | Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc. | Ownership

Companies that own Zynerba Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
523,406
3.95%
-28,270
0%
06/30/2018
Horizons ETFs Management (Canada), Inc.
343,450
2.59%
1,902
0.22%
07/31/2018
BlackRock Fund Advisors
236,234
1.78%
-431,125
0%
06/30/2018
Millennium Management LLC
224,511
1.69%
120,570
0%
06/30/2018
Pennsylvania Trust Co.
172,100
1.3%
-13,000
0.06%
06/30/2018
Susquehanna Financial Group LLLP
120,391
0.91%
120,391
0%
06/30/2018
HighTower Advisors LLC
83,393
0.63%
0
0.01%
06/30/2018
BlueCrest Capital Management (UK) LLP
81,590
0.62%
81,590
0.02%
06/30/2018
Marshall Wace North America LP
76,339
0.57%
76,339
0%
06/30/2018
Geode Capital Management LLC
75,787
0.56%
-25,515
0%
06/30/2018

About Zynerba Pharmaceuticals

View Profile
Address
80 West Lancaster Avenue
Devon Pennsylvania 19333
United States
Employees -
Website http://zynerba.com
Updated 07/08/2019
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. The company was founded by Audra L.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.